Anand Reddi
About Anand Reddi
Anand Reddi is the Vice President of Global Strategic Initiatives and Corporate Operations at BeiGene, with extensive experience in biotechnology and global health.
VP at BeiGene
Anand Reddi currently holds the position of Vice President, Global Strategic Initiatives and Corporate Operations at BeiGene. He also serves as Chief of Staff to the Chairman and CEO. Based in the San Francisco Bay Area, Reddi joined BeiGene in 2023. His experience and leadership roles in both strategic initiatives and corporate operations reflect his extensive expertise in the biotechnology sector.
Previous Roles at Adverum Biotechnologies
From 2021 to 2023, Anand Reddi held multiple leadership roles at Adverum Biotechnologies, including Vice President of Business Development and Commercial Planning, Vice President of Government Affairs & Policy, and Vice President of Investor Relations & Corporate Communications. He also served as Vice President, Chief of Staff, and Vice President of Patient Advocacy, Global Market Access, and Digital Innovation. During his tenure, Reddi was instrumental in driving corporate strategy, policy, and investor relations for the company.
Leadership at Gilead Sciences
Anand Reddi had a significant tenure at Gilead Sciences between 2014 and 2021. He held various influential roles, including Head of Digital Innovation, Customer Engagement, Global Marketing, and Global Product Strategy. He was instrumental in launching 12 blockbuster medicines that benefited over 25 million patients in 140 countries. He also led the design and implementation of Gilead’s global health initiatives, such as the Tanzania Test & Treat Initiative and the PrEP Hub™ platform.
Academic Background and Research
Anand Reddi has a strong academic background with degrees from the University of Michigan and the University of Colorado School of Medicine. He holds a Master of Science and a medical degree (M.D. Candidate). He was also a J. William Fulbright Scholar in South Africa, where he studied global health and HIV/AIDS. In addition, he has published over 20 peer-reviewed publications in prestigious journals like Science, Nature, and JAMA.
Board Memberships and Advisory Roles
Throughout his career, Anand Reddi has been actively involved in several advisory and board roles. He served on the board of directors of Hepion Pharmaceuticals (NASDAQ: HEPA) from 2022 to 2024. He was also a vice-chair on the board of directors of the Bay Area Global Health Alliance and a past member of the board of directors of the AIDS Healthcare Foundation. These roles underscore his commitment to advancing global health and biotechnology initiatives.